Nucleotide Excision Repair is Elevated in Stage IV Commonly Used Breast Cancer Cell Lines as Compared to Stage I Cultures
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.
Part of the Pharmacy and Pharmaceutical Sciences Commons
Works by Nancy Lalanne in Pharmacy and Pharmaceutical Sciences
2019
Nucleotide Excision Repair is Elevated in Commercially Available Late Stage Breast Cancer Cell Lines as Compared to Early Stage Explants
Faculty Proceedings, Presentations, Posters, Speeches, Lectures, etc.